↓ Skip to main content

Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study

Overview of attention for article published in BMC Cancer, October 2022
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
11 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Association between the efficacy and immune-related adverse events of pembrolizumab and chemotherapy in non-small cell lung cancer patients: a retrospective study
Published in
BMC Cancer, October 2022
DOI 10.1186/s12885-022-10133-1
Pubmed ID
Authors

Kana Kurokawa, Yoichiro Mitsuishi, Naoko Shimada, Yuta Kawakami, Keita Miura, Taichi Miyawaki, Tetsuhiko Asao, Ryo Ko, Takehito Shukuya, Rina Shibayama, Shuko Nojiri, Kazuhisa Takahashi

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 11 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 11 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 1 9%
Other 1 9%
Student > Doctoral Student 1 9%
Student > Bachelor 1 9%
Researcher 1 9%
Other 1 9%
Unknown 5 45%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 27%
Unspecified 1 9%
Biochemistry, Genetics and Molecular Biology 1 9%
Medicine and Dentistry 1 9%
Unknown 5 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 October 2022.
All research outputs
#20,875,908
of 23,493,900 outputs
Outputs from BMC Cancer
#6,642
of 8,491 outputs
Outputs of similar age
#353,302
of 442,522 outputs
Outputs of similar age from BMC Cancer
#135
of 224 outputs
Altmetric has tracked 23,493,900 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,491 research outputs from this source. They receive a mean Attention Score of 4.4. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 442,522 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 224 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.